Vasoactive drugs and the kidney

Best Practice and Research: Clinical Anaesthesiology

Volumn 18, Issue 1, 2004, Pages 53-74

  Lee, Raymond Wai Chuen ^a   Di Giantomasso, David ^a   May, Clive ^a   Bellomo, Rinaldo ^b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

Acute renal failure; Dopamine; Dopexamine; Epinephrine (adrenalin); Kidney; Levosimendan; Milrinone; Norepinephrine (noradrenalin); Terlipressin; Vasopressin; Vasopressors

Indexed keywords

ADRENALIN; AMRINONE; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CONTRAST MEDIUM; CREATININE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ENOXIMONE; FENOLDOPAM; LEVOSIMENDAN; METHYLENE BLUE; MILRINONE; NORADRENALIN; PHENYLEPHRINE; PLACEBO; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN; CARDIOTONIC AGENT; CARDIOVASCULAR AGENT; CATECHOLAMINE;

ACUTE KIDNEY FAILURE; BURN; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CLINICAL STUDY; CLINICAL TRIAL; CRITICAL ILLNESS; DATA ANALYSIS; DRUG INDUCED DISEASE; DRUG MECHANISM; ENDOCRINE DISEASE; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; OUTCOMES RESEARCH; PATHOGENESIS; PERFUSION PRESSURE; POPULATION RESEARCH; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINE VOLUME; DRUG EFFECT; INTENSIVE CARE; KIDNEY; KIDNEY CIRCULATION; PATHOPHYSIOLOGY;

CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; CATECHOLAMINES; HUMANS; INTENSIVE CARE; KIDNEY; KIDNEY FAILURE, ACUTE; RENAL CIRCULATION;

EID: 2142823718     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2003.09.005     Document Type: Review

References (96)

1. Bellomo R. Cole L. Ronco C. Hemodynamic support and the role of dopamine Kidney International 66 1998 S71-S74
2. Sladen R.N. Landry D. Renal blood flow regulation, autoregulation, and vasomotor nephropathy Anesthesiology Clinics of North America 18 2000 791-807
3. Schrier R.W. Effects of the adrenergic nervous system and catecholamines on systemic and renal hemodynamics, sodium and water excretion, and renin secretion Kidney International 6 1974 291-306
4. Schnermann J. The juxtaglomerular apparatus: from anatomical peculiarity to physiological relevance Journal of the American Society of Nephrology 14 2003 1681-1694
5. Papaioannides D. Bouropoulos C. Sinapides D. et al. Acute renal dysfunction associated with selective COX-2 inhibitor therapy International Journal of Urology and Nephrology 33 2001 609-611
6. Ronco C. Bellomo R. Prevention of acute renal failure in the critically ill Nephron Clinical Practice 93 2003 c13-c20
7. Kelleher S.P. Robinette J.B. Conger J.D. Sympathetic nervous system in the loss of autoregulation in acute renal failure American Journal of Physiology 264 1984 F379-F386
8. Bellomo R. Kellum J.A. Wisniewski S.R. et al. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs American Journal of Respiratory and Critical Care Medicine 159 1999 1186-1192
9. Treggiari M.M. Romand J.A. Burgener D. et al. Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock Critical Care Medicine 30 2002 1334-1339
10. LeDoux D. Astiz M.E. Carpati C.M. et al. Effects of perfusion pressure on tissue perfusion in septic shock Critical Care Medicine 28 2000 2729-2732
11. De Backer D. Vincent J.L. Norepinephrine administration in septic shock: how much is enough? Critical Care Medicine 30 2002 1398-1399
12. Rudis M.I. Basha M.A. Zarowitz B.J. Is it time to reposition vasopressors and inotropes in sepsis? Critical Care Medicine 24 1996 525-537
13. Mousdale S. Clyburn P.A. Mackie A.M. et al. Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers British Journal of Clinical Pharmacology 25 1988 555-560
14. Goldberg L.I. Cardiovascular and renal actions of dopamine. Potential clinical applications Pharmacological Review 24 1972 1-29
15. McDonald R. Goldberg L. McNay J. et al. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow Journal of Clinical Investigation 43 1964 1116-1124
16. Bersten A.D. Rutten A.J. Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis Critical Care Medicine 23 1995 537-544
17. Duke G.J. Briedis J.H. Weaver R.A. Renal support in critically ill patients: low dose dopamine or low dose dobutamine Critical Care Medicine 22 1994 1919-1925
18. Olson D. Pohlman A. Hall J.B. Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance American Journal of Respiratory and Critical Care Medicine 154 1996 1664-1670
19. Strigle T.R. Petrinec D. The effect of renal range dopamine and norepinephrine on the renal vasculature American Surgeon 56 1990 494-496
20. Graves T.A. Cioffi W.G. Vaughan G.M. et al. The renal effects of low-dose dopamine in thermally injured patients Journal of Trauma 35 1993 97-102
21. Day N.P.J. Phu N.H. Mai N.T.H. et al. Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis Critical Care Medicine 28 2000 1353-1362
22. Mehta R.L. Pascual M.T. Soroko S. et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure Journal of the American Medical Association 288 2002 2547-2553
23. Swygert T.H. Roberts L.C. Valek T.R. et al. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients Anesthesiology 75 1991 571-576
24. Gray P.A. Bodenham A.R. Park G.R. et al. A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation Anaesthesia 46 1991 638-641
25. Polson R.J. Park G.R. Lindop M.J. et al. The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine Anaesthesia 42 1987 15-19
26. Kadieva V.S. Friedman L. Margolius L.P. et al. The effect of dopamine on graft function in patients undergoing renal transplantation Anesthesia and Analgesia 76 1993 362-365
27. Delosangeles A. Baquero A. Bannett A. Dopamine and furosemide infusion for prevention of post-transplant oliguric renal failure Kidney International 27 1985 339-343
28. Myles P.S. Buckland M.R. Schenk N.J. et al. Effect of 'renal-dose' dopamine on renal function following cardiac surgery Anaesthesia and Intensive Care 21 1993 56-61
29. Lassnigg A. Donner E. Grubhofer G. et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery Journal of the American Society of Nephrology 11 2000 97-104
30. Costa P. Ottino G.M. Matani A. et al. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction Journal of Cardiothoracic Anesthesiology 4 1990 469-473
31. Yavuz S. Ayabakan N. Goncu M.T. et al. Effect of combined dopamine and diltiazem on renal function after cardiac surgery Medical Science Monitor 8 2002 145-150
32. Baldwin L. Henderson A. Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery Annals of Internal Medicine 120 1994 744-747
33. de Lasson L. Hansen H.E. Juhl B. et al. A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery European Journal of Vascular and Endovascular Surgery 10 1995 82-90
34. Paul M.D. Mazer C.D. Byrick R.J. et al. Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man American Journal of Nephrology 6 1986 427-434
35. Henderson I.S. Beattie T.J. Kennedy A.C. Dopamine hydrochloride in oliguric states Lancet ii 1980 827-828
36. Parker S. Carlon G. Isaacs M. et al. Dopamine administration in oliguria and oliguric renal failure Critical Care Medicine 9 1981 630-632
37. Lumlertgul D. Keoplung M. Sitprija V. et al. Furosemide and dopamine in malarial acute renal failure Nephron 52 1989 40-44
38. Desjars P. Pinaud M. Potel G. et al. A reappraisal of norepinephrine therapy in human septic shock Critical Care Medicine 15 1987 134-137
39. Marik P.E. Iglesias J. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria American Journal of Medicine 107 1999 387-390
40. Lherm T. Troche G. Rossignol M. et al. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines Intensive Care Medicine 22 1996 213-219
41. Ichai C. Passeron C. Carles M. et al. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: a single-blind, prospective, controlled study Critical Care Medicine 28 2000 1329-1335
42. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial Lancet 356 2000 2139-2143
43. Delzell J.E.Jr. Is low-dose dopamine effective in preventing renal dysfunction in patients in the intensive care unit (ICU)? Journal of Family Practice 50 2001 369
44. Holmes C.L. Walley K.R. Bad medicine: low-dose dopamine in the ICU Chest 123 2003 1266-1275
45. Sandham J.D. Hull R.D. Brant R.F. et al. A Randomized, controlled trial of the use of pulmonary-artery catheters in high risk surgical patients New England Journal of Medicine 348 2003 5-14
46. Singer I. Epstein M. Potential of dopamine A1 agonists in the management of acute renal failure American Journal of Kidney Diseases 31 1998 743-755
47. Mathur V.S. Swan S.K. Lambrecht L.J. et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects Critical Care Medicine 27 1999 1832-1837
48. Tumlin J.A. Wang A. Murray P.T. et al. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy American Heart Journal 143 2002 894-903
49. Kini A.S. Mitre C.A. Kamran M. et al. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam American Journal of Cardiology 89 2002 999-1002
50. Kini A.S. Mitre C.A. Kim M. et al. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam Catheter and Cardiovascular Intervention 55 2002 169-173
51. Garwood S. Davis E. Hines R.L. Fenoldopam: an effective renal preservation agent in cardiac surgery Anesthesiology 91 1999 A154
52. Halpenny M. Lakshmi S. O'Donnell A. et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting Anaesthesia 56 2001 953-960
53. Gilbert T.B. Hasnain J.U. Flinn W.R. et al. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair Journal of Cardiovascular Pharmacology and Therapy 6 2001 31-36
54. Sheinbaum R. Ignacio C. Safi H.J. et al. Contemporary strategies to preserve renal function during cardiac and vascular surgery Reviews in Cardiovascular Medicine 4 supplement 1 2003 S21-S28
55. Meier-Hellmann A. Reinhart K. Effects of catecholamines on regional perfusion and oxygenation in critically ill patients Acta Anaesthesiologica Scandinavica 107 supplement 1995 239-248
56. Hoogenberg K. Smit A.J. Girbes A.R.J. The effects of dopamine on noradrenaline induced change in blood pressure and renal haemodyanmics in healthy volunteers: is there a role for routine use of dopamine in septic shock? European Journal of Clinical Investigation 27 supplement 1 1997 A17
57. Richer M. Robert S. Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man Critical Care Medicine 24 1996 1150-1156
58. Di Giantomasso D. May C.N. Bellomo R. Norepinephrine and vital organ blood flow Intensive Care Medicine 28 2002 1804-1809
59. Bellomo R. Giantomasso D. Noradrenaline and the kidney: friends or foes? Critical Care 5 2001 294-298
60. Desjars P. Pinaud M. Bugnon D. et al. Norepinephrine therapy has no deleterious renal effects in human septic shock Critical Care Medicine 17 1989 426-429
61. Fukuoka T. Nishimura M. Imanaka H. et al. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate level Critical Care Medicine 17 1989 1104-1107
62. Martin C. Viviand X. Arnaud S. et al. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients Critical Care Medicine 27 1999 1708-1713
63. Redl-Wenzl E.M. Armbruster C. Edelmann G. et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states Intensive Care Medicine 19 1993 151-154
64. Morimatsu M. Uchino S. Chung J. et al. Norepinephrine for severe vasodilatation after cardiac surgery: impact on renal function Intensive Care Medicine 29 2003 1106-1112
65. Bersten A.D. Rutten A.J. Summersides G. et al. Epinephrine infusion in sheep: systemic and renal hemodynamic effects Critical Care Medicine 22 1994 994-1001
66. Prengel A.W. Lindner K.H. Wenzel V. et al. Splanchnic and renal blood flow after cardiopulmonary resuscitation with epinephrine and vasopressin in pigs Resuscitation 38 1998 19-24
67. Voelckel W.G. Lindner K.H. Wenzel V. et al. Effects of vasopressin and epinephrine on splanchnic blood flow and renal function during and after cardiopulmonary resuscitation in pigs Critical Care Medicine 28 2000 1083-1088
68. Sato Y. Matsuzawa H. Eguchi S. Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery Japan Circulation Journal 46 1982 1059-1072
69. Lema G. Canessa R. Phenylephrine, dopamine, mannitol, and renal protection during cardiopulmonary bypass Anesthesia and Analgesia 87 1998 1459-1463
70. Bennett S. McKeown J. Griffin S. Effect of angiotensin and phenylephrine on renal function in cardiac surgical patients Heart 79 supplement 1 1998 28-31
71. Gregory J.S. Bonfiglio M.F. Dasta J.F. et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock Crit. Care Med. 19 1991 1395-1400
72. Kanbank M. Phenylephrine, dopamine, mannitol and renal protection during cardiopulmonary bypass Anaesth. Analg. 87 1998 1458-1459
73. Westman L. Jarnberg P.O. Effects of dobutamine on renal function in normal man Acta Anaesthesiologica Scandinavica 30 1986 72-75
74. Wenstone R. Campbell J.M. Booker P.D. et al. Renal function after cardiopulmonary bypass in children: comparison of dopamine with dobutamine British Journal of Anaesthesia 67 1991 591-594
75. MacGregor D.A. Butterworth J.F. Zaloga C.P. et al. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting Chest 106 1994 835-841
76. Tan L.B. Littler W.A. Murray R.G. Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure Journal of Cardiovascular Pharmacology 10 1987 280-286
77. Magrini F. Foulds R. Roberts N. et al. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors European Journal of Clinical Pharmacology 32 1987 1-4
78. Baumann G. Felix S.B. Filcek S.A. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output American Journal of Cardiology 65 1990 748-754
79. Ralph C.J. Tanser S.J. MacNaughton P.D. et al. A randomised controlled trial investigating the effects of dopexamine on gastrointestinal function and organ dysfunction in the critically ill Intensive Care Medicine 28 2002 884-890
80. Berendes E. Mollhoff T. Van Aken H. et al. Effects of dopexamine on creatinine clearance, systemic inflammation and splanchnic oxygenation in patients undergoing coronary artery bypass grafting Anesthesia and Analgesia 84 1997 950-957
81. Sherry E. Tooley M.A. Bolsin S.N. et al. Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery European Journal of Anaesthesiology 14 1997 184-189
82. Dehne M.G. Klein T.F. Muhling J. Hempelmann G. et al. Impairment of renal function after cardiopulmonary bypass is not influenced by dopexamine Renal Failure 23 2001 217-230
83. Wilson J. Woods I. Fawcett J. et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery British Medical Journal 318 1999 1099-1103
84. Konstam M.A. Cody R.J. Short-term use of intravenous milrinone for heart failure American Journal Cardiology 75 1995 822-826
85. Cody R.J. Renal and hormonal effects of phosphodiesterase III inhibition in congestive heart failure American Journal of Cardiology 63 1989 31A-34A
86. Saab G. Mindel G. Ewald G. et al. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis American Journal of Kidney Diseases 40 2002 E7
87. Figgitt D.P. Gillies P.S. Goa K.L. Levosimendan Drugs 61 2001 613-627
88. Oldner A. Konrad D. Weitzberg E. et al. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock Critical Care Medicine 29 2001 2185-2193
89. Holmes C.L. Patel B.M. Russell J.A. et al. Physiology of vasopressin relevant to management of septic shock Chest 120 2001 989-1002
90. Landry D.W. Levin H.R. Gallant E.M. et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock Critical Care Medicine 25 1997 1279-1282
91. Tsuneyoshi I. Yamada H. Kakihana Y. et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock Critical Care Medicine 29 2001 487-493
92. Patel B.M. Chittock D.R. Russell J.A. et al. Beneficial effects of short-term vasopressin infusion during severe septic shock Anesthesiology 96 2002 576-582
93. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care International consensus on science Circulation 102 supplement 2000 I1-384
94. Lindner K.H. Prengel A.W. Pfenninger E.G. et al. Cardiopulmonary resuscitation: vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs Circulation 91 1995 215-221
95. Scharte M. Meyer J. van Aken H. et al. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep Critical Care Medicine 29 2001 1756-1760
96. O'Brien A. Clapp L. Singer M. Terlipressin for norepinephrine-resistant septic shock Lancet 359 2002 1209-1210